Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Protagonist Therapeutics Inc buy SVB Leerink LLC

Start price
€53.00
12.09.25 / 50%
Target price
€62.24
12.09.26
Performance (%)
39.62%
Price
€74.00
03.12.25
Summary
This prediction is currently active. With a performance of 39.62% the BUY prediction by SVB_Leerink_LLC is a big success. This prediction currently runs until 12.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Protagonist Therapeutics Inc - -
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

Comments by SVB_Leerink_LLC for this prediction

In the thread Protagonist Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 39.62%
Target price 62.240
Change
Ends at 12.09.26

Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $73.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat